| 1 |
Xu Y, Xu X, Ni X, Pan J, Chen M, Lin Y, Zhao Z, Zhang L, Ge N, Song G, Zhang J. Gene-based cancer-testis antigens as prognostic indicators in hepatocellular carcinoma. Heliyon 2023;9:e13269. [PMID: 36950598 DOI: 10.1016/j.heliyon.2023.e13269] [Reference Citation Analysis]
|
| 2 |
Raza S, Rajak S, Srivastava J, Tewari A, Gupta P, Chakravarti B, Ghosh S, Chaturvedi CP, Sinha RA. ULK1 inhibition attenuates telomerase activity in hepatic cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2022;1869:119355. [DOI: 10.1016/j.bbamcr.2022.119355] [Reference Citation Analysis]
|
| 3 |
Deng Z, Huang K, Liu D, Luo N, Liu T, Han L, Du D, Lian D, Zhong Z, Peng J. Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:1607-22. [PMID: 34956967 DOI: 10.2147/JHC.S337067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 4 |
Li GS, Yang LJ, Chen G, Huang SN, Fang YY, Huang WJ, Lu W, He J, Liu HC, Li LY, Mo BY, Lu HP. Laryngeal Squamous Cell Carcinoma: Clinical Significance and Potential Mechanism of Cell Division Cycle 45. Cancer Biother Radiopharm 2021. [PMID: 34672813 DOI: 10.1089/cbr.2020.4314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Raja A, Haq F. Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications. J Cancer Res Clin Oncol 2021. [PMID: 34623518 DOI: 10.1007/s00432-021-03826-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Qiu MJ, Zhang L, Chen YB, Zhu LS, Zhang B, Li QT, Yang SL, Xiong ZF. KIF18B as a regulator in tumor microenvironment accelerates tumor progression and triggers poor outcome in hepatocellular carcinoma. Int J Biochem Cell Biol 2021;137:106037. [PMID: 34217812 DOI: 10.1016/j.biocel.2021.106037] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 7 |
Liu P, Wei J, Mao F, Xin Z, Duan H, Du Y, Wang X, Li Z, Qian J, Yao J. Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Endoplasmic Reticulum Stress-Related Gene Analysis. Front Oncol 2021;11:641487. [PMID: 34094926 DOI: 10.3389/fonc.2021.641487] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 8 |
Zhang P, Feng J, Wu X, Chu W, Zhang Y, Li P. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases. Pathol Oncol Res 2021;27:588532. [PMID: 34257537 DOI: 10.3389/pore.2021.588532] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 9 |
Zhu W, Ru L, Ma Z. Identification of a Novel Four-Gene Signature Correlated With the Prognosis of Patients With Hepatocellular Carcinoma: A Comprehensive Analysis. Front Oncol 2021;11:626654. [PMID: 33777771 DOI: 10.3389/fonc.2021.626654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Lu HP, Du XF, Li JD, Huang SN, He RQ, Wu HY, Li MF, Wu WZ, Chen JT, Mo WJ, Chen G. Expression of Cell Division Cycle Protein 45 in Tissue Microarrays and the CDC45 Gene by Bioinformatics Analysis in Human Hepatocellular Carcinoma and Patient Outcomes. Med Sci Monit 2021;27:e928800. [PMID: 33622998 DOI: 10.12659/MSM.928800] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 11 |
Zheng R, Lai G, Li R, Hao Y, Cai L, Jia J. Increased expression of MCM4 is associated with poor prognosis in patients with hepatocellular carcinoma. J Gastrointest Oncol 2021;12:153-73. [PMID: 33708433 DOI: 10.21037/jgo-20-574] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 12 |
Yang Z, Zi Q, Xu K, Wang C, Chi Q. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm. Int Immunopharmacol 2021;90:107238. [PMID: 33316739 DOI: 10.1016/j.intimp.2020.107238] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 13 |
Li GS, Hou W, Chen G, Yao YX, Chen XY, Zhang XG, Liang Y, Li MX, Huang ZG, Dang YW, Liang QH, Wu HY, Li RQ, Wei HY. Clinical Significance of Integrin Subunit Beta 4 in Head and Neck Squamous Cell Carcinoma. Cancer Biother Radiopharm 2020. [PMID: 33179959 DOI: 10.1089/cbr.2020.3943] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 14 |
Yang H, Wang Y, Zhang Z, Li H. Identification of KIF18B as a Hub Candidate Gene in the Metastasis of Clear Cell Renal Cell Carcinoma by Weighted Gene Co-expression Network Analysis. Front Genet 2020;11:905. [PMID: 32973873 DOI: 10.3389/fgene.2020.00905] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 15 |
Wang Y, Chen H, Zhang J, Cheng ASL, Yu J, To KF, Kang W. MCM family in gastrointestinal cancer and other malignancies: From functional characterization to clinical implication. Biochim Biophys Acta Rev Cancer 2020;1874:188415. [PMID: 32822825 DOI: 10.1016/j.bbcan.2020.188415] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 16 |
Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauß A, Blaudszun AR, Yevsa T, Fricke S, Kossatz-Boehlert U. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Front Immunol 2020;11:1280. [PMID: 32849491 DOI: 10.3389/fimmu.2020.01280] [Cited by in Crossref: 149] [Cited by in F6Publishing: 165] [Article Influence: 49.7] [Reference Citation Analysis]
|
| 17 |
Wyld L, Bellantuono I, Tchkonia T, Morgan J, Turner O, Foss F, George J, Danson S, Kirkland JL. Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies. Cancers (Basel) 2020;12:E2134. [PMID: 32752135 DOI: 10.3390/cancers12082134] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 19.3] [Reference Citation Analysis]
|
| 18 |
Xie H, Liu S, Zhang Z, Chen P, Tao Y. A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma. J Cancer 2020;11:5768-81. [PMID: 32913470 DOI: 10.7150/jca.44573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Ouyang G, Yi B, Pan G, Chen X. A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma. Cancer Cell Int 2020;20:207. [PMID: 32514252 DOI: 10.1186/s12935-020-01294-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 20 |
Zhu Z, Li L, Xu J, Ye W, Chen B, Zeng J, Huang Z. Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma. PeerJ 2020;8:e9201. [PMID: 32518728 DOI: 10.7717/peerj.9201] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 21 |
Hu WY, Wei HY, Liu LY, Li KM, Wang RB, Xu XQ, Feng R. miR-3607, a biomarker of hepatocellular carcinoma invasion and aggressiveness: Its relationship with epithelial-mesenchymal transition process. IUBMB Life 2020;72:1686-97. [PMID: 32311821 DOI: 10.1002/iub.2291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Qiu L, Zhan K, Malale K, Wu X, Mei Z. Transcriptomic profiling of peroxisome-related genes reveals a novel prognostic signature in hepatocellular carcinoma. Genes & Diseases 2020. [DOI: 10.1016/j.gendis.2020.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 23 |
Zhong Y, Jiang L, Long X, Zhou Y, Deng S, Lin H, Li X. Clinical Significance And Integrative Analysis Of Kinesin Family Member 18B In Lung Adenocarcinoma. Onco Targets Ther 2019;12:9249-64. [PMID: 31807007 DOI: 10.2147/OTT.S227438] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 24 |
Li G, Xu W, Zhang L, Liu T, Jin G, Song J, Wu J, Wang Y, Chen W, Zhang C, Chen X, Ding Z, Zhu P, Zhang B. Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma. EBioMedicine 2019;47:128-41. [PMID: 31492561 DOI: 10.1016/j.ebiom.2019.08.064] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
|
